BMH BRÄUTIGAM advises capiton on entry into Wundex
BMH BRÄUTIGAM advised financial investor capiton on the acquisition of a majority stake in Wundex Group.
Wundex is a full-service provider for integrated wound care. For more than 25 years, the group has specialized in the development of high-quality homecare wound treatment, especially in the field of anti-decubitus prophylaxis as well as in the distribution of modern wound care products. The focus is on patients with chronic wounds. Thanks to comprehensive advisory services pro-vided by specially trained wound managers and a modern logistics infrastructure, wound patients are optimally cared for. In addition, the group distributes about 60,000 different wound care products.
Both founders will retain a significant shareholding and will continue to run the day-to-day operations of the company as managing directors. Capiton and management plan to grow the business organically as well as through acquisitions of smaller players in this fragmented market.
The transaction is still subject to the usual market reservations.
Background: The team of BMH BRÄUTIGAM have been advising capiton on the acquisition and sale of companies for more than 20 years, most recently on the sale of its stake in Trioptics to Jenoptik and the acquisition of Cedes Group.
Team BMH BRÄUTIGAM: Tina Schmidt (Lead), Jan-Peter Heyer, Till Wansleben, David Thüning (all Private Equity ǀ Corporate/M&A), Dr. Andrea Reichert-Clauß (Merger Clearance), Dr. Sylko Winkler (Financing)